ALLMedicine™ Prostate Cancer Center
Research & Reviews 29,515 results
https://doi.org/10.1073/pnas.2018976118
Proceedings of the National Academy of Sciences of the Un... Shrestha E, Coulter JB et. al.
Aug 4th, 2021 - Prostate adenocarcinoma is the second most commonly diagnosed cancer in men worldwide, and the initiating factors are unknown. Oncogenic TMPRSS2:ERG (ERG+) gene fusions are facilitated by DNA breaks and occur in up to 50% of prostate cancers. Infe...
https://doi.org/10.1016/j.urolonc.2021.06.008
Urologic Oncology; Wenzel M, Hussein R et. al.
Aug 4th, 2021 - To evaluate the impact of PSMA PET (prostate specific membrane antigen positron emission tomography) findings prior to salvage radiotherapy (SRT) in recurrent prostate cancer (PCa) after radical prostatectomy (RP) on metastasis-free survival (MFS)...
https://doi.org/10.1016/j.urolonc.2021.07.011
Urologic Oncology; Savin Z, Dekalo S et. al.
Aug 4th, 2021 - Concurrent systematic biopsies during image-guided targeted biopsies of the prostate were found to improve the detection rate of clinically significant prostate cancer (CSPC). However, these biopsies do not routinely include anterior or apical sam...
https://doi.org/10.1007/s10147-021-02002-x 10.1016/s0360-3016(97)00926-7 10.1016/j.ijrobp.2016.06.2455 10.1016/s1470-2045(18)30528-x 10.1038/s41585-019-0213-3 10.1016/j.clon.2016.02.005 10.1038/s41391-018-0034-0 10.1097/COC.0000000000000133 10.1007/s00432-017-2375-9 10.1016/j.ijrobp.2018.10.003 10.1200/JCO.20.03282 10.3389/fonc.2019.00751 10.1016/j.ijrobp.2017.07.041 10.1016/0360-3016(94)90138-4 10.1007/s10147-019-01478-y 10.1016/j.ijrobp.2006.04.029 10.1016/j.urolonc.2020.09.026 10.1002/pst.433 10.1038/bmt.2012.244 10.1016/j.radonc.2019.12.006 10.1016/j.eururo.2018.03.030 10.1111/cas.13911 10.1016/j.ijrobp.2019.09.044 10.1016/j.eururo.2019.03.022
International Journal of Clinical Oncology; Aizawa R, Nakamura K et. al.
Aug 3rd, 2021 - The aim of this study was to evaluate the long-term efficacy and safety of whole pelvic intensity-modulated radiation therapy with a simultaneous-integrated boost (WP-SIB-IMRT) for locally advanced prostate cancer (LAPCa). All patients with cT3-4N...
https://doi.org/10.1177/10668969211035844
International Journal of Surgical Pathology; Galea LA, Mow C et. al.
Aug 3rd, 2021 - The 2016 World Health Organization classification of prostate cancer with neuroendocrine (NE) differentiation includes NE cells in usual prostate cancer, adenocarcinoma with Paneth cell-like NE differentiation, well-differentiated NE tumor (carcin...
Guidelines 63 results
https://doi.org/10.1016/j.prro.2020.10.002
Practical Radiation Oncology; Zietman AL,
Dec 15th, 2020 - ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but Changing Role for the Radiation Oncologist.|2020|Zietman AL, ,|
https://doi.org/10.1097/JU.0000000000001376
The Journal of Urology; Lowrance WT, Breau RH et. al.
Sep 23rd, 2020 - The summary presented herein represents Part II of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients with castration-resistant disease. Please refer ...
https://doi.org/10.1097/JU.0000000000001375
The Journal of Urology; Lowrance WT, Breau RH et. al.
Sep 23rd, 2020 - The summary presented herein represents Part I of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients with biochemical recurrence without metastatic di...
https://doi.org/10.1016/j.prro.2020.06.009
Practical Radiation Oncology; Bauman GS, Jani AB
Sep 7th, 2020 - American Society for Radiation Oncology Editorial: Rapidly Evolving Technologies Related to Imaging Strategies for Advanced Prostate Cancer.|2020|Bauman GS,Jani AB,|
https://doi.org/10.1002/pros.24053
The Prostate REFERENCES; Shore ND, Drake CG et. al.
Aug 12th, 2020 - Advanced prostate cancer (PC) patients, especially those with metastatic prostate cancer (mPC), often require complex management pathways. Despite the publication of clinical practice guidelines by leading urological and oncological organizations ...
Drugs 195 results see all →
Clinicaltrials.gov 2,000 results
https://clinicaltrials.gov/ct2/show/NCT02407054
May 7th, 2020 - The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as LY3023414 in combination with enzalutamide in men with prostate cancer.
https://clinicaltrials.gov/ct2/show/NCT01377753
May 6th, 2020 - Background: Pilot study is designed to evaluate the safety and feasibility of thermal laser ablation of focal prostate tumors. Prostate cancer is relatively slow growing, with doubling times for local tumors estimated at 2 to 4 years. Some prostat...
https://clinicaltrials.gov/ct2/show/NCT02499835
May 6th, 2020 - PRIMARY OBJECTIVES: I. To evaluate the safety of pembrolizumab in combination with pTVG-HP (pTVG-HP plasmid DNA vaccine) in patients with castration-resistant, metastatic prostate cancer. II. To determine the 6-month progression-free survival and ...
https://clinicaltrials.gov/ct2/show/NCT02470897
May 5th, 2020 - PRIMARY OBJECTIVES: I. To evaluate the incidence of genitourinary (GU) and gastrointestinal (GI) acute and late toxicity for patients treated with prostate stereotactic body radiotherapy (SBRT) with simultaneous integrative boost, urethral ring sp...
https://clinicaltrials.gov/ct2/show/NCT03706365
May 5th, 2020 - This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednisone...
News 3,004 results
https://www.medscape.com/viewarticle/955117
Jul 21st, 2021 - (Reuters Health) - Several therapies commonly used to treat men with metastatic castration-resistant prostate cancer don't appear to cause a significant decline in cognitive function, a small study suggests. Researchers examined data on 155 men 65...
https://www.medscape.com/viewarticle/954951
Jul 19th, 2021 - NEW YORK (Reuters Health) - Transperineal prostate biopsy with local anesthesia is safe and achieved similar outcomes to sedation in detecting clinically significant cancer in a small retrospective study. "The transperineal approach to prostate bi...
https://www.medscape.com/viewarticle/954899
Jul 16th, 2021 - The Institute of Cancer Research (ICR) has expressed disappointment at the decision by The National Institute for Health and Care Excellence (NICE) not to approve abiraterone as a first-line treatment for newly diagnosed, advanced prostate cancer....
https://www.medscape.com/viewarticle/954395
Jul 9th, 2021 - More good tidings to gladden the hearts of men who have reached the half century mark: Swapping traditional prostate biopsies for MRI-targeted biopsies with a new prostate cancer risk score can cut the number of unnecessary biopsies in half while ...
https://www.medscape.com/viewarticle/954460
Jul 9th, 2021 - NEW YORK (Reuters Health) - In high-risk prostate cancer patients with at least one additional adverse feature, guideline-concordant multimodal care was associated with greater prostate cancer-specific survival (PCSS) in a large retrospective stud...
